Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
Summary<br />
Cumulative %<br />
Positive net benefit<br />
Recruitment<br />
The overall recruitment rate was 75%, and 25<br />
patients were withdrawn, providing 322 patients in<br />
the study. Nineteen per cent of patients were lost<br />
to follow-up 7 days after discharge.<br />
Clinical outcomes<br />
• Children were significantly more sick with sevoflurane/sevoflurane<br />
than with propofol/halothane.<br />
• No gender difference was found in terms of<br />
the rate of PONV. An additional risk factor<br />
associated with PONV is agitation in recovery.<br />
• The overall overnight admission rate was<br />
only 1.2%.<br />
Resource use<br />
• The length of hospital stay was not different<br />
between randomisation arms, but variable costs<br />
and total costs were significantly higher in the<br />
sevoflurane/sevoflurane arm.<br />
• There were extremely low postdischarge costs to<br />
both the NHS and the parents, demonstrating<br />
that day-surgery discharge policies were<br />
clinically appropriate.<br />
© Queen’s Printer and Controller of HMSO 2002. All rights reserved.<br />
<strong>Health</strong> <strong>Technology</strong> Assessment 2002; Vol. 6: No. 30<br />
Positive net cost<br />
–1500 –1300 –1100 –900 –700 –500 –300 –100 0 100 300 500 700<br />
Net cost (£)<br />
FIGURE 27 The cumulative percentage of the net cost <strong>for</strong> each anaesthetic regimen in the paediatric study (–––, sevoflurane/<br />
sevoflurane; - - -, propofol/halothane)<br />
Patient preferences and CV<br />
• Parents whose children had not had the mask<br />
(sevoflurane) be<strong>for</strong>e did not want it in the<br />
future. Parents whose children had not had the<br />
injection (propofol) be<strong>for</strong>e did not want it in<br />
the future. On the whole, parents were happy<br />
with the technique their children received.<br />
• Those parents who would choose the same<br />
induction method in the future as that which<br />
their child had received tended to give higher<br />
CVs than those who chose the alternative<br />
method <strong>for</strong> induction, but the differences<br />
were not statistically significant.<br />
• Parents did not give higher CVs <strong>for</strong> avoiding<br />
PONV if their child had received sevoflurane/<br />
sevoflurane. Parents gave higher CVs <strong>for</strong> their<br />
children to avoid PONV than did the adult<br />
patients to avoid PONV themselves.<br />
• There was no significant difference in CVs<br />
<strong>for</strong> maintenance anaesthesia between those<br />
parents whose children had and had not<br />
experienced PONV.<br />
Cost-effectiveness analysis<br />
Propofol/halothane was the most effective<br />
and least costly (£3.50 per patient, rate of<br />
79